Published in J Neurol Neurosurg Psychiatry on April 01, 1989
Subcutaneous apomorphine in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 1.54
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 1.01
The modern management of Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 0.99
Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up. J Neurol Neurosurg Psychiatry (1998) 0.86
Sublingual apomorphine and Parkinson's disease. J Neurol Neurosurg Psychiatry (1989) 0.84
Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry (1995) 0.78
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma? J Psychiatry Neurosci (2001) 0.77
Advanced stages of PD: interventional therapies and related patient-centered care. J Neural Transm (Vienna) (2015) 0.76
Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 0.76
Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet (1988) 2.80
Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. N Engl J Med (1976) 1.40
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (1979) 1.27
Apomorphine infusion for motor fluctuations in Parkinson's disease. Lancet (1987) 1.12
Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med (1989) 6.79
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain (2005) 4.33
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet (1991) 3.89
Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg (1996) 3.37
Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol (1987) 3.14
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet (1995) 3.06
Parasite sequestration in Plasmodium falciparum malaria: spleen and antibody modulation of cytoadherence of infected erythrocytes. Proc Natl Acad Sci U S A (1983) 2.84
Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen. J Exp Med (1983) 2.76
Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg (2002) 2.62
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol (2001) 2.45
Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 2.21
The impact on Parkinson's disease of electrical parameter settings in STN stimulation. Neurology (2002) 2.14
Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology (2012) 2.12
Small, clonally variant antigens expressed on the surface of the Plasmodium falciparum-infected erythrocyte are encoded by the rif gene family and are the target of human immune responses. J Exp Med (1999) 2.11
Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain (2009) 1.91
Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology (2002) 1.89
Mutations within the MGC4607 gene cause cerebral cavernous malformations. Am J Hum Genet (2004) 1.88
Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease. Neurology (2000) 1.85
The impact of deep brain stimulation on executive function in Parkinson's disease. Brain (2000) 1.74
A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology (2008) 1.74
The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasitol (1978) 1.70
Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66
Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep (1995) 1.66
Is it clinically possible to distinguish nonhemorrhagic infarct from hemorrhagic stroke? Stroke (1995) 1.60
Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop (2001) 1.57
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol (1999) 1.57
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain (1998) 1.56
Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol (1997) 1.48
The core assessment program for intracerebral transplantation. Mov Disord (1995) 1.47
Long-term electrical inhibition of deep brain targets in movement disorders. Mov Disord (1998) 1.47
Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett (1995) 1.43
Mixed infections with Plasmodium falciparum and P malariae and fever in malaria. Lancet (1994) 1.42
Inhibition of levodopa effects by internal pallidal stimulation. Mov Disord (1998) 1.42
Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience (2000) 1.41
[French language training course: malaria workshop organized by Institut Pasteur de Madagascar]. Med Trop (Mars) (2007) 1.40
[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39
Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions. Neurology (2001) 1.39
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39
Plasmodium chabaudi: a rodent malaria model for in-vivo and in-vitro cytoadherence of malaria parasites in the absence of knobs. Parasite Immunol (1987) 1.38
Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord (1995) 1.28
Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord (2001) 1.27
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease. Lancet (1979) 1.27
Infarction in the territory of the medial branch of the posterior inferior cerebellar artery. J Neurol Neurosurg Psychiatry (1990) 1.26
Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease. Eur Respir J (1992) 1.24
Effect of chronic bilateral subthalamic nucleus (STN) stimulation on postural control in Parkinson's disease. Brain (2003) 1.23
Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol (1998) 1.23
Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health (2004) 1.20
Deep brain stimulation in the treatment of severe dystonia. J Neurol (2001) 1.19
Antigen detection immunoassay using dipsticks and colloidal dyes. J Immunol Methods (1991) 1.19
Experimental infection of the squirrel monkey (Saimiri sciureus) with Plasmodium falciparum. J Parasitol (1980) 1.18
Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir Suppl (Wien) (1993) 1.18
Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation. Mov Disord (1998) 1.17
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology (2000) 1.16
Expression of strain-specific surface antigens on Plasmodium falciparum-infected erythrocytes. Parasite Immunol (1982) 1.14
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Subthalamic nucleus, sensorimotor cortex and muscle interrelationships in Parkinson's disease. Brain (2001) 1.13
Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry (2007) 1.12
EGF receptor amplification and expression in human brain tumours. Eur J Cancer (1992) 1.12
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 1.12
Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain (2001) 1.11
Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry (2007) 1.11
Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) (1995) 1.11
Long-term prognosis of symptomatic lacunar infarcts. A hospital-based study. Stroke (1994) 1.10
Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol (1989) 1.09
Venous sinus thrombosis associated with androgens in a healthy young man. Stroke (1994) 1.08
Proceedings: A trypanosomatid parasite of laboratory-bred Culicoides variipennis. Trans R Soc Trop Med Hyg (1975) 1.08
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord (1996) 1.08
Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang (2001) 1.08